News

Coventry and Alan Buerger Move to Dismiss Abacus Lawsuit

  • Motion underscores that Abacus's claims lack merit as Lapetus, its key life expectancy provider, shut its doors August 31 FORT WASHINGTON, Pa. , Sept. 2, 2025 /PRNewswire/ -- Coventry First LLC ("Coventry") and its Co-Founder and Executive Chairman, Alan H.
    09/02/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL).  Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext. 7980.
    08/17/2025
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

Abacus Life, Inc. (ABL) can sell. Click on Rating Page for detail.

The price of Abacus Life, Inc. (ABL) is 6.55 and it was updated on 2025-09-13 07:00:23.

Currently Abacus Life, Inc. (ABL) is in undervalued.

News
    
News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc. - ABL

  • NEW YORK , Aug. 16, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
    Sat, Aug. 16, 2025

Abacus Life CEO on record growth and 2025 outlook – ICYMI

  • Abacus Global Management (NASDAQ:ABL) earlier this week reported record financial results and raised its 2025 guidance. The company said it nearly doubled both revenue and adjusted net income year over year in 2024 and has continued its momentum into 2025.
    Fri, Aug. 15, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL).  Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext. 7980.
    Wed, Aug. 13, 2025

ABACUS (ABL) ALERT: Bragar Eagel & Squire, P.C. Continues Investigating Abacus Global Management, Inc. on Behalf of Abacus Stockholders and Encourages Investors to Contact the Firm

  • If you purchased or acquired stock in Abacus and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
    Tue, Aug. 12, 2025

Dynasty Financial Partners and Abacus Global Management Announce Minority Investment

  • ST. PETERSBURG, Fla.--(BUSINESS WIRE)--Dynasty Financial Partners (“Dynasty”), a leading provider of technology-enabled wealth management solutions for independent financial advisors, today announced a minority investment in Abacus Global Management, Inc. (“Abacus”) (NASDAQ: ABL), a leader in the alternative asset management space. In turn, Abacus has made a minority investment in Dynasty. Abacus is a member of the network of owners and operators of independent firms leveraging Dynasty's integr.
    Tue, Aug. 12, 2025
SEC Filings
SEC Filings

Abacus Life, Inc. (ABL) - 15-12G

  • SEC Filings
  • 08/26/2025

Abacus Life, Inc. (ABL) - 25-NSE

  • SEC Filings
  • 08/14/2025

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 08/11/2025

Abacus Life, Inc. (ABL) - 425

  • SEC Filings
  • 07/31/2025

Abacus Life, Inc. (ABL) - SC TO-I/A

  • SEC Filings
  • 07/30/2025

Abacus Life, Inc. (ABL) - 425

  • SEC Filings
  • 07/30/2025

Abacus Life, Inc. (ABL) - EFFECT

  • SEC Filings
  • 07/29/2025

Abacus Life, Inc. (ABL) - 424B3

  • SEC Filings
  • 07/29/2025

Abacus Life, Inc. (ABL) - SC TO-I/A

  • SEC Filings
  • 07/15/2025

Abacus Life, Inc. (ABL) - S-4/A

  • SEC Filings
  • 07/15/2025

Abacus Life, Inc. (ABL) - SC TO-I

  • SEC Filings
  • 06/30/2025

Abacus Life, Inc. (ABL) - S-4

  • SEC Filings
  • 06/30/2025

Abacus Life, Inc. (ABL) - 425

  • SEC Filings
  • 06/30/2025

Abacus Life, Inc. (ABL) - 425

  • SEC Filings
  • 06/27/2025

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 06/06/2025

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 05/13/2025

Abacus Life, Inc. (ABL) - DEFA14A

  • SEC Filings
  • 04/28/2025

Abacus Life, Inc. (ABL) - DEF 14A

  • SEC Filings
  • 04/28/2025

Abacus Life, Inc. (ABL) - ARS

  • SEC Filings
  • 04/28/2025

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 04/03/2025

Abacus Life, Inc. (ABL) - EFFECT

  • SEC Filings
  • 02/05/2025

Abacus Life, Inc. (ABL) - 424B3

  • SEC Filings
  • 02/04/2025

Abacus Life, Inc. (ABL) - CORRESP

  • SEC Filings
  • 01/31/2025

Abacus Life, Inc. (ABL) - UPLOAD

  • SEC Filings
  • 01/29/2025

Abacus Life, Inc. (ABL) - S-3

  • SEC Filings
  • 01/16/2025

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 12/23/2024

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 12/18/2024

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 12/16/2024

Abacus Life, Inc. (ABL) - SC 13D

  • SEC Filings
  • 12/10/2024

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 12/10/2024

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 11/27/2024

Abacus Life, Inc. (ABL) - 424B7

  • SEC Filings
  • 11/25/2024

Abacus Life, Inc. (ABL) - 424B2

  • SEC Filings
  • 11/25/2024

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 11/25/2024

Abacus Life, Inc. (ABL) - 424B7

  • SEC Filings
  • 11/21/2024

Abacus Life, Inc. (ABL) - 424B2

  • SEC Filings
  • 11/21/2024

Abacus Life, Inc. (ABL) - EFFECT

  • SEC Filings
  • 11/15/2024

Abacus Life, Inc. (ABL) - EFFECT

  • SEC Filings
  • 11/15/2024

Abacus Life, Inc. (ABL) - CORRESP

  • SEC Filings
  • 11/13/2024

Abacus Life, Inc. (ABL) - UPLOAD

  • SEC Filings
  • 11/07/2024

Abacus Life, Inc. (ABL) - CORRESP

  • SEC Filings
  • 11/07/2024

Abacus Life, Inc. (ABL) - UPLOAD

  • SEC Filings
  • 11/06/2024

Abacus Life, Inc. (ABL) - CORRESP

  • SEC Filings
  • 11/04/2024

Abacus Life, Inc. (ABL) - UPLOAD

  • SEC Filings
  • 11/01/2024

Abacus Life, Inc. (ABL) - S-3

  • SEC Filings
  • 10/21/2024

Abacus Life, Inc. (ABL) - POS AM

  • SEC Filings
  • 10/21/2024

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 07/09/2024

Abacus Life, Inc. (ABL) - S-8

  • SEC Filings
  • 06/28/2024

Abacus Life, Inc. (ABL) - 424B1

  • SEC Filings
  • 06/21/2024

Abacus Life, Inc. (ABL) - EFFECT

  • SEC Filings
  • 06/20/2024

Abacus Life, Inc. (ABL) - CORRESP

  • SEC Filings
  • 06/17/2024

Abacus Life, Inc. (ABL) - S-1/A

  • SEC Filings
  • 06/13/2024

Abacus Life, Inc. (ABL) - S-1/A

  • SEC Filings
  • 05/31/2024

Abacus Life, Inc. (ABL) - CORRESP

  • SEC Filings
  • 05/30/2024

Abacus Life, Inc. (ABL) - UPLOAD

  • SEC Filings
  • 05/21/2024

Abacus Life, Inc. (ABL) - S-1

  • SEC Filings
  • 05/10/2024

Abacus Life, Inc. (ABL) - DEFA14A

  • SEC Filings
  • 04/29/2024

Abacus Life, Inc. (ABL) - DEF 14A

  • SEC Filings
  • 04/29/2024

Abacus Life, Inc. (ABL) - ARS

  • SEC Filings
  • 04/29/2024

Abacus Life, Inc. (ABL) - DRS

  • SEC Filings
  • 04/26/2024

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 02/15/2024

Abacus Life, Inc. (ABL) - SC 13G/A

  • SEC Filings
  • 02/13/2024

Abacus Life, Inc. (ABL) - 424B3

  • SEC Filings
  • 02/13/2024

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 02/13/2024

Abacus Life, Inc. (ABL) - SC 13G/A

  • SEC Filings
  • 02/12/2024

Abacus Life, Inc. (ABL) - S-1/A

  • SEC Filings
  • 02/09/2024

Abacus Life, Inc. (ABL) - EFFECT

  • SEC Filings
  • 02/09/2024

Abacus Life, Inc. (ABL) - UPLOAD

  • SEC Filings
  • 02/07/2024

Abacus Life, Inc. (ABL) - CORRESP

  • SEC Filings
  • 02/07/2024

Abacus Life, Inc. (ABL) - S-1

  • SEC Filings
  • 01/31/2024

Abacus Life, Inc. (ABL) - CERT

  • SEC Filings
  • 11/21/2023

Abacus Life, Inc. (ABL) - 8-A12B

  • SEC Filings
  • 11/20/2023

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 11/20/2023

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 11/13/2023

Abacus Life, Inc. (ABL) - 424B3

  • SEC Filings
  • 11/06/2023

Abacus Life, Inc. (ABL) - EFFECT

  • SEC Filings
  • 11/02/2023

Abacus Life, Inc. (ABL) - S-1/A

  • SEC Filings
  • 11/01/2023

Abacus Life, Inc. (ABL) - CORRESP

  • SEC Filings
  • 10/31/2023

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 10/31/2023

Abacus Life, Inc. (ABL) - S-1/A

  • SEC Filings
  • 10/30/2023

Abacus Life, Inc. (ABL) - CORRESP

  • SEC Filings
  • 10/30/2023

Abacus Life, Inc. (ABL) - S-8

  • SEC Filings
  • 10/26/2023

Abacus Life, Inc. (ABL) - SC 13D/A

  • SEC Filings
  • 10/20/2023

Abacus Life, Inc. (ABL) - SC 13D/A

  • SEC Filings
  • 10/17/2023

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 10/17/2023

Abacus Life, Inc. (ABL) - EFFECT

  • SEC Filings
  • 10/13/2023

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 10/13/2023

Abacus Life, Inc. (ABL) - CORRESP

  • SEC Filings
  • 10/11/2023

Abacus Life, Inc. (ABL) - UPLOAD

  • SEC Filings
  • 10/10/2023

Abacus Life, Inc. (ABL) - S-1/A

  • SEC Filings
  • 09/29/2023

Abacus Life, Inc. (ABL) - CORRESP

  • SEC Filings
  • 09/29/2023

Abacus Life, Inc. (ABL) - UPLOAD

  • SEC Filings
  • 09/27/2023

Abacus Life, Inc. (ABL) - S-1

  • SEC Filings
  • 09/18/2023

Abacus Life, Inc. (ABL) - S-1/A

  • SEC Filings
  • 09/15/2023

Abacus Life, Inc. (ABL) - CORRESP

  • SEC Filings
  • 09/15/2023

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 08/24/2023

Abacus Life, Inc. (ABL) - UPLOAD

  • SEC Filings
  • 08/10/2023

Abacus Life, Inc. (ABL) - SC 13G/A

  • SEC Filings
  • 08/09/2023

Abacus Life, Inc. (ABL) - S-1

  • SEC Filings
  • 07/25/2023

Abacus Life, Inc. (ABL) - SC 13D

  • SEC Filings
  • 07/10/2023

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 07/10/2023

Abacus Life, Inc. (ABL) - 3

  • SEC Filings
  • 07/10/2023

Abacus Life, Inc. (ABL) - 25-NSE

  • SEC Filings
  • 07/03/2023

Abacus Life, Inc. (ABL) - DEFA14A

  • SEC Filings
  • 06/26/2023

Abacus Life, Inc. (ABL) - DEFM14A

  • SEC Filings
  • 06/14/2023

Abacus Life, Inc. (ABL) - DEFA14A

  • SEC Filings
  • 06/14/2023

Abacus Life, Inc. (ABL) - DEFA14A

  • SEC Filings
  • 06/13/2023

Abacus Life, Inc. (ABL) - PRER14A

  • SEC Filings
  • 06/05/2023

Abacus Life, Inc. (ABL) - SC 13G

  • SEC Filings
  • 05/19/2023

Abacus Life, Inc. (ABL) - PRER14A

  • SEC Filings
  • 04/21/2023

Abacus Life, Inc. (ABL) - DEFA14A

  • SEC Filings
  • 04/20/2023

Abacus Life, Inc. (ABL) - DEFA14A

  • SEC Filings
  • 04/17/2023

Abacus Life, Inc. (ABL) - UPLOAD

  • SEC Filings
  • 03/02/2023

Abacus Life, Inc. (ABL) - SC 13G/A

  • SEC Filings
  • 02/14/2023

Abacus Life, Inc. (ABL) - SC 13G

  • SEC Filings
  • 02/14/2023

Abacus Life, Inc. (ABL) - SC 13G/A

  • SEC Filings
  • 02/10/2023

Abacus Life, Inc. (ABL) - PRER14A

  • SEC Filings
  • 02/03/2023

Abacus Life, Inc. (ABL) - CORRESP

  • SEC Filings
  • 02/02/2023

Abacus Life, Inc. (ABL) - UPLOAD

  • SEC Filings
  • 01/25/2023

Abacus Life, Inc. (ABL) - SC 13D/A

  • SEC Filings
  • 01/24/2023

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 01/24/2023

Abacus Life, Inc. (ABL) - PRER14A

  • SEC Filings
  • 01/18/2023

Abacus Life, Inc. (ABL) - CORRESP

  • SEC Filings
  • 01/17/2023

Abacus Life, Inc. (ABL) - UPLOAD

  • SEC Filings
  • 01/06/2023

Abacus Life, Inc. (ABL) - DEF 14A

  • SEC Filings
  • 12/30/2022

Abacus Life, Inc. (ABL) - PRE 14A

  • SEC Filings
  • 12/20/2022

Abacus Life, Inc. (ABL) - DEFA14A

  • SEC Filings
  • 12/20/2022

Abacus Life, Inc. (ABL) - PRER14A

  • SEC Filings
  • 12/07/2022

Abacus Life, Inc. (ABL) - DEFA14A

  • SEC Filings
  • 12/07/2022

Abacus Life, Inc. (ABL) - CORRESP

  • SEC Filings
  • 12/07/2022

Abacus Life, Inc. (ABL) - DEFA14A

  • SEC Filings
  • 12/02/2022

Abacus Life, Inc. (ABL) - 3

  • SEC Filings
  • 11/30/2022

Abacus Life, Inc. (ABL) - UPLOAD

  • SEC Filings
  • 11/10/2022

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 11/02/2022

Abacus Life, Inc. (ABL) - DEFA14A

  • SEC Filings
  • 10/19/2022

Abacus Life, Inc. (ABL) - PREM14A

  • SEC Filings
  • 10/14/2022

Abacus Life, Inc. (ABL) - DEFA14A

  • SEC Filings
  • 10/14/2022

Abacus Life, Inc. (ABL) - DEFA14A

  • SEC Filings
  • 08/30/2022

Abacus Life, Inc. (ABL) - SC 13D

  • SEC Filings
  • 07/27/2022

Abacus Life, Inc. (ABL) - 3

  • SEC Filings
  • 07/27/2022

Abacus Life, Inc. (ABL) - DEFA14A

  • SEC Filings
  • 07/19/2022

Abacus Life, Inc. (ABL) - UPLOAD

  • SEC Filings
  • 07/01/2022

Abacus Life, Inc. (ABL) - DEF 14A

  • SEC Filings
  • 07/01/2022

Abacus Life, Inc. (ABL) - CORRESP

  • SEC Filings
  • 07/01/2022

Abacus Life, Inc. (ABL) - CORRESP

  • SEC Filings
  • 06/29/2022

Abacus Life, Inc. (ABL) - UPLOAD

  • SEC Filings
  • 06/27/2022

Abacus Life, Inc. (ABL) - PRE 14A

  • SEC Filings
  • 06/21/2022

Abacus Life, Inc. (ABL) - SC 13G

  • SEC Filings
  • 02/14/2022

Abacus Life, Inc. (ABL) - SC 13G/A

  • SEC Filings
  • 02/10/2022

Abacus Life, Inc. (ABL) - SC 13G/A

  • SEC Filings
  • 02/09/2022

Abacus Life, Inc. (ABL) - 3

  • SEC Filings
  • 09/22/2021

Abacus Life, Inc. (ABL) - SC 13G/A

  • SEC Filings
  • 02/11/2021

Abacus Life, Inc. (ABL) - SC 13G

  • SEC Filings
  • 02/10/2021

Abacus Life, Inc. (ABL) - SC 13G/A

  • SEC Filings
  • 02/09/2021

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 11/09/2020

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 10/29/2020

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 09/24/2020

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 09/22/2020

Abacus Life, Inc. (ABL) - 4/A

  • SEC Filings
  • 08/06/2020

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 08/05/2020

Abacus Life, Inc. (ABL) - SC 13G

  • SEC Filings
  • 08/03/2020

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 07/31/2020

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 07/30/2020

Abacus Life, Inc. (ABL) - 4

  • SEC Filings
  • 07/28/2020

Abacus Life, Inc. (ABL) - 424B3

  • SEC Filings
  • 07/24/2020

Abacus Life, Inc. (ABL) - EFFECT

  • SEC Filings
  • 07/22/2020

Abacus Life, Inc. (ABL) - CERT

  • SEC Filings
  • 07/22/2020

Abacus Life, Inc. (ABL) - 8-A12B

  • SEC Filings
  • 07/22/2020

Abacus Life, Inc. (ABL) - 3

  • SEC Filings
  • 07/22/2020

Abacus Life, Inc. (ABL) - S-1/A

  • SEC Filings
  • 07/20/2020

Abacus Life, Inc. (ABL) - CORRESP

  • SEC Filings
  • 07/20/2020

Abacus Life, Inc. (ABL) - S-1

  • SEC Filings
  • 07/02/2020

Abacus Life, Inc. (ABL) - DRS

  • SEC Filings
  • 06/08/2020
Press Releases
StockPrice Release
More Headlines
News

Abacus Global takes minority stake in Dynasty Financial Partners

  • Abacus Global Management (NASDAQ:ABL) said on Tuesday it has taken a minority stake in Dynasty Financial Partners, a provider of technology-enabled wealth management solutions for independent financial advisers. The companies have an existing relationship, with Abacus already part of Dynasty's network of independent firms using its technology, services, turnkey asset management program, digital lead generation tools, capital solutions and investment bank.
  • 08/12/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK , Aug. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext.
  • 08/11/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL).  Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext. 7980.
  • 08/09/2025

Abacus Global Management, Inc. (ABL) Q2 2025 Earnings Call Transcript

  • Abacus Global Management, Inc. (NASDAQ:ABL ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Elena Plesco - Chief Capital Officer Jay J. Jackson - CEO, President & Chairman Robert F.
  • 08/09/2025

Abacus Global shares surge after raised outlook, record Q2 results

  • Shares of Abacus Global Management (NASDAQ:ABL) jumped 10.2% on Friday morning after the company raised its full-year earnings outlook and posted a second straight quarter of record growth. The alternative asset manager lifted its 2025 adjusted earnings forecast to a range of $74 million to $80 million, citing strong demand for policyholder liquidity and inflows into its new asset management offerings.
  • 08/08/2025

Abacus Life, Inc. (ABL) Q2 Earnings and Revenues Surpass Estimates

  • Abacus Life, Inc. (ABL) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.18 per share a year ago.
  • 08/07/2025

Abacus Global raises 2025 outlook after doubling Q2 revenue

  • Abacus Global Management Inc. (NASDAQ: ABL) raised its full-year earnings outlook on Wednesday after reporting a second quarter of record growth, driven by rising demand for its life solutions offerings and expanding asset management platform. The alternative asset manager said total revenue surged 93% year-over-year to $56.2 million for the quarter to end June 2025, while adjusted net income rose 87% to $21.9 million.
  • 08/07/2025

Abacus Global Management Reports Second Quarter 2025 Results

  • - Second Quarter 2025 Total Revenue Nearly Doubles Year-over-Year to $56.2 Million - - Longevity Funds Attracted $123.1 Million in Capital Inflows - - GAAP Net Income of $17.6 Million - - Adjusted Net Income Grew 87% Year-over-Year to $21.9 Million - - Adjusted EBITDA Grew 89% Year-over-Year to $31.5 Million – ~ Raises Full Year 2025 Outlook ~ ORLANDO, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today reported results for the second quarter ended June 30, 2025.
  • 08/07/2025

Dorel Provides Update on Long-Term Debt

  • MONTRÉAL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Dorel Industries Inc. (TSX: DII.B, DII.A) today announced that on August 7, 2025, it again amended its asset backed loan (ABL) facility and term loan facility whereby Dorel's lenders agreed to continue to forebear from enforcing their rights and exercising their remedies under both the ABL facility and term loan facility further to a default by Dorel relating to certain financial covenants. The initial forbearance period commenced on May 9, 2025 and has now been extended to the earlier of September 16, 2025 and the occurrence of any event of default, other than the current event of default, under the ABL facility or term loan facility. Dorel will receive access to US$20.0 million additional liquidity in three tranches under the ABL facility in order to finance new inventory and must continue to provide the lenders with additional reporting during the forbearance period. In addition, the total maximum availability under the ABL facility was decreased to US$150.0 million as part of the amendment. As at June 30, 2025, the total amount of borrowings outstanding under the ABL facility was approximately US$92.0 million.
  • 08/07/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK , Aug. 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
  • 08/06/2025

Abacus Life, Inc. (ABL) Expected to Beat Earnings Estimates: Should You Buy?

  • Abacus Life, Inc. (ABL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 07/31/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK , July 31, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext.
  • 07/31/2025

Abacus Global Management completes warrant exchange offer

  • Abacus Global Management (NASDAQ:ABL) has completed its previously announced exchange offer and consent solicitation, resulting in the elimination of all outstanding public and private placement warrants. The alternative asset manager issued 4.18 million shares of common stock in exchange for the warrants tendered.
  • 07/31/2025

Abacus Global Management Announces Successful Completion of Exchange Offer and Consent Solicitation

  • ORLANDO, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today announced the completion of its previously announced exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) relating to its (i) outstanding public warrants (the “public warrants”) and (ii) outstanding private placement warrants (the “private placement warrants” and, together with the public warrants, the “warrants”) to purchase shares of common stock, par value $0.0001 per share, of the Company (“common stock”). The Company's common stock and public warrants are listed on the Nasdaq Capital Market (the “Nasdaq”) under the symbols “ABL” and “ABLLW,” respectively. The Company issued 4,183,160 shares of common stock in exchange for the warrants tendered in the Offer.
  • 07/30/2025

Abacus Global Management Announces Successful Warrant Exchange Offer

  • ORLANDO, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a leader in the alternative asset management space, today announced the expiration and results of its previously announced exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) relating to its (i) outstanding public warrants (the “public warrants”) and (ii) outstanding private placement warrants (the “private placement warrants” and, together with the public warrants, the “warrants”) to purchase shares of common stock, par value $0.0001 per share, of the Company (“common stock”). The Offer and Consent Solicitation expired at 11:59 p.m., Eastern Time, on July 29, 2025.
  • 07/30/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL).  Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext. 7980.
  • 07/28/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK , July 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
  • 07/27/2025

Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report – Hagens Berman

  • SAN FRANCISCO, July 23, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (NASDAQ: ABL) is under mounting pressure as its stock continues to slide, driven by a series of damning reports from Morpheus Research—a newly formed investigative group led by analysts who previously worked at the renowned Hindenburg Research. Despite Abacus's public denials and the announcement of a $20 million share repurchase program, investor confidence remains shaken, with shares now down more than 36% over the past month.
  • 07/23/2025

Wolf Popper LLP Announces Investigation on Behalf of Abacus Global Management, Inc. Investors

  • NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Wolf Popper LLP is investigating potential claims on behalf of purchasers of Abacus Global Management, Inc. (“Abacus”) common stock (NASDAQ: ABL).
  • 07/22/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK , July 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext.
  • 07/22/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL).  Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext. 7980.
  • 07/18/2025

Will Abacus Life, Inc. (ABL) Beat Estimates Again in Its Next Earnings Report?

  • Abacus Life, Inc. (ABL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
  • 07/17/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK , July 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext.
  • 07/17/2025

Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report – Hagens Berman

  • SAN FRANCISCO, July 15, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (NASDAQ: ABL) is under mounting pressure as its stock continues to slide, driven by a series of damning reports from Morpheus Research—a newly formed investigative group led by analysts who previously worked at the renowned Hindenburg Research. Despite Abacus's public denials and the announcement of a $20 million share repurchase program, investor confidence remains shaken, with shares now down more than 36% over the past month.
  • 07/15/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK , July 12, 2025 /PRNewswire/ -- P is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
  • 07/12/2025

DXP Enterprises, Inc. Announces Amendment of ABL Revolver

  • HOUSTON--(BUSINESS WIRE)-- #DXPE--DXP Enterprises, Inc. (NASDAQ: DXPE) today announced that on July 1, 2025, DXP Enterprises, Inc. (the “Company”) entered into an Increase Agreement (the “Increase Agreement”) by and among the Company and certain of the Company's subsidiaries as borrowers, certain other subsidiaries of the Company as guarantors, pursuant to which the aggregate commitments under the Company's existing asset-based revolving credit facility (the “ABL Facility”) were increased by $50 millio.
  • 07/08/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc. - ABL

  • NEW YORK , July 7, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
  • 07/07/2025

Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report – Hagens Berman

  • SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (NASDAQ: ABL) is under mounting pressure as its stock continues to slide, driven by a series of damning reports from Morpheus Research—a newly formed investigative group led by analysts who previously worked at the renowned Hindenburg Research. Despite Abacus's public denials and the announcement of a $20 million share repurchase program, investor confidence remains shaken, with shares now down more than 36% over the past month.
  • 07/07/2025

Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report – Hagens Berman

  • SAN FRANCISCO, July 02, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (NASDAQ: ABL) is under mounting pressure as its stock continues to slide, driven by a series of damning reports from Morpheus Research—a newly formed investigative group led by analysts who previously worked at the renowned Hindenburg Research. Despite Abacus's public denials and the announcement of a $20 million share repurchase program, investor confidence remains shaken, with shares now down more than 36% over the past month.
  • 07/02/2025

Coventry Responds to Baseless Lawsuit by Abacus Global Management, Inc.

  • FORT WASHINGTON, Pa. , July 2, 2025 /PRNewswire/ -- Coventry, the leader and creator of the secondary market for life insurance, today released the following statement: "Abacus's (NASDAQ: ABL) lawsuit is its latest misdirection and a transparent ploy designed to delay accountability and deflect attention from serious problems of Abacus's own making," said Alan Buerger, Coventry's Chairman.
  • 07/02/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK , July 2, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
  • 07/02/2025

Abacus Global Management sues Coventry alleging defamation and anticompetitive conduct

  • Abacus Global Management (NASDAQ:ABL) announced that it has filed a lawsuit against Coventry First LLC and its chairman, Alan Buerger, alleging a coordinated campaign to defame the company and damage its business through anticompetitive practices. The complaint was filed in Florida's Ninth Circuit Court.
  • 07/02/2025

Abacus Global Management Sues Coventry and its Chairman Alan Buerger for Defamation and Anticompetitive Conduct

  • Coventry and Chairman Alan Buerger Engaged in Years-Long Campaign to Systematically Disseminate False and Misleading Information About the Publicly-Traded Company
  • 07/01/2025

Wolf Popper LLP Announces Investigation on Behalf of Abacus Global Management, Inc. Investors

  • NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Wolf Popper LLP is investigating potential claims on behalf of purchasers of Abacus Global Management, Inc. (“Abacus”) common stock (NASDAQ: ABL).
  • 07/01/2025

Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report – Hagens Berman

  • SAN FRANCISCO, June 30, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (NASDAQ: ABL) is under mounting pressure as its stock continues to slide, driven by a series of damning reports from Morpheus Research—a newly formed investigative group led by analysts who previously worked at the renowned Hindenburg Research. Despite Abacus's public denials and the announcement of a $20 million share repurchase program, investor confidence remains shaken, with shares now down more than 36% over the past month.
  • 06/30/2025

Abacus Global Management Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants

  • ORLANDO, Fla., June 30, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today announced that it has commenced an exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) relating to its (i) outstanding public warrants (the “public warrants”) and (ii) outstanding private placement warrants (the “private placement warrants” and, together with the public warrants, the “warrants”) to purchase shares of common stock, par value $0.0001 per share, of the Company (“common stock”). The Company's common stock and public warrants are listed on the Nasdaq Capital Market under the symbols “ABL” and “ABLLW,” respectively. The purpose of the Offer and Consent Solicitation is to simplify the Company's capital structure and reduce the potential dilutive impact of the warrants, thereby providing the Company with more flexibility for financing its operations in the future.
  • 06/30/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL).  Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext. 7980.
  • 06/28/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK , June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
  • 06/27/2025

Abacus Global Management Announces Intention to Conduct Exchange Offer and Consent Solicitation Relating to Warrants

  • ORLANDO, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (the “Company”) (NASDAQ: ABL), today announced that it intends to conduct an exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) relating to its outstanding (i) public warrants to purchase shares of common stock of the Company, par value $0.0001 per share (“common stock”), which warrants trade on The Nasdaq Capital Market under the symbol “ABLLW” (“public warrants”), and (ii) private placement warrants to purchase shares of common stock (such private placement warrants, together with the public warrants, the “warrants”).
  • 06/27/2025

Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report - Hagens Berman

  • SAN FRANCISCO , June 25, 2025 /PRNewswire/ -- Abacus Global Management, Inc. (NASDAQ: ABL) is under mounting pressure as its stock continues to slide, driven by a series of damning reports from Morpheus Research—a newly formed investigative group led by analysts who previously worked at the renowned Hindenburg Research. Despite Abacus's public denials and the announcement of a $20 million share repurchase program, investor confidence remains shaken, with shares now down more than 36% over the past month.
  • 06/25/2025

INVESTOR ALERT: Investigation of Abacus Global Management, Inc. (ABL) Announced by Holzer & Holzer, LLC

  • ATLANTA, June 25, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL) complied with federal securities laws. On June 4, 2025, Morpheus Research published a report alleging that Abacus's returns “are primarily manufactured by the systematic overvaluation of its assets through an opaque ‘mark to model' accounting scheme that closely mirrors past blow-ups in the life settlements industry.” Following this report, the price of the Company's stock dropped.
  • 06/25/2025

Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report – Hagens Berman

  • SAN FRANCISCO, June 23, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (NASDAQ: ABL) is under mounting pressure as its stock continues to slide, driven by a series of damning reports from Morpheus Research—a newly formed investigative group led by analysts who previously worked at the renowned Hindenburg Research. Despite Abacus's public denials and the announcement of a $20 million share repurchase program, investor confidence remains shaken, with shares now down more than 36% over the past month.
  • 06/23/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL).  Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext. 7980.
  • 06/23/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK , June 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
  • 06/22/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL).  Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext. 7980.
  • 06/18/2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Abacus Global Management, Inc. (ABL) And Encourages Investors to Connect

  • NEW YORK, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Abacus Global Management, Inc. ("Abacus" or "the Company") (NASDAQ:ABL). Investors who purchased Abacus securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ABL.
  • 06/17/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK , June 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
  • 06/17/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc. - ABL

  • NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ:ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
  • 06/16/2025

Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report - Hagens Berman

  • SAN FRANCISCO, CA / ACCESS Newswire / June 16, 2025 / Investors in Abacus Global Management, Inc. (NASDAQ:ABL) experienced another substantial decline in share price today following the release of a second scathing report from Morpheus Research. Morpheus, a collective of financial analysts known for their focus on uncovering alleged fraud and corporate malfeasance, has now published two critical analyses of Abacus within a week, alleging the life settlements company has engaged in improper accounting.
  • 06/16/2025

Bronstein, Gewirtz & Grossman, LLC Encourages Abacus Global Management, Inc. (ABL) Stockholders to Inquire about Securities Investigation

  • NEW YORK, NY / ACCESS Newswire / June 16, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Abacus Global Management, Inc. ("Abacus" or "the Company") (NASDAQ:ABL). Investors who purchased Abacus securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ABL.
  • 06/16/2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Abacus Global Management, Inc. (ABL) And Encourages Stockholders to Reach Out

  • NEW YORK, NY / ACCESS Newswire / June 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Abacus Global Management, Inc. ("Abacus" or "the Company") (NASDAQ:ABL). Investors who purchased Abacus securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ABL.
  • 06/15/2025

Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report – Hagens Berman

  • SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- Investors in Abacus Global Management, Inc. (NASDAQ: ABL) experienced another substantial decline in share price today following the release of a second scathing report from Morpheus Research. Morpheus, a collective of financial analysts known for their focus on uncovering alleged fraud and corporate malfeasance, has now published two critical analyses of Abacus within a week, alleging the life settlements company has engaged in improper accounting.
  • 06/14/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc. - ABL

  • NEW YORK, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ:ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
  • 06/13/2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Abacus Global Management, Inc. (ABL) And Encourages Stockholders to Connect

  • NEW YORK, NY / ACCESS Newswire / June 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Abacus Global Management, Inc. ("Abacus" or "the Company") (NASDAQ:ABL). Investors who purchased Abacus securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ABL.
  • 06/13/2025

Abacus Global Management, Inc. (ABL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

  • NEW YORK, NY / ACCESS Newswire / June 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Abacus Global Management, Inc. ("Abacus" or "the Company") (NASDAQ:ABL). Investors who purchased Abacus securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ABL.
  • 06/12/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK , June 12, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
  • 06/12/2025

ABL Investors Have Opportunity to Join Abacus Global Management, Inc. Fraud Investigation with the Schall Law Firm

  • LOS ANGELES , June 11, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or "the Company") (NASDAQ: ABL) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
  • 06/11/2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Abacus Global Management, Inc. (ABL) and Encourages Stockholders to Learn More About the Investigation

  • NEW YORK, NY / ACCESS Newswire / June 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Abacus Global Management, Inc. ("Abacus" or "the Company") (NASDAQ:ABL). Investors who purchased Abacus securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ABL.
  • 06/11/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK, NY / ACCESS Newswire / June 11, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ:ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
  • 06/11/2025

Bronstein, Gewirtz & Grossman, LLC Encourages Abacus Global Management, Inc. (ABL) Investors to Inquire about Securities Investigation

  • NEW YORK, NY / ACCESS Newswire / June 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Abacus Global Management, Inc. ("Abacus" or "the Company") (NASDAQ:ABL). Investors who purchased Abacus securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ABL.
  • 06/10/2025

Abacus Global reaffirms asset values, receives analyst backing amid short-seller attack

  • Abacus Global Management (NASDAQ:ABL) on Tuesday firmly rejected allegations raised in a June 4 short-seller report, calling the claims “false and uninformed” and defending the integrity of its asset valuation practices. The Orlando-based alternative asset manager said the short report's two central assertions—that Abacus relies excessively on a single life expectancy provider, Lapetus Solutions, and that this inflates its balance sheet—are both incorrect.
  • 06/10/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL).  Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext. 7980.
  • 06/10/2025

Abacus Refutes Misleading Balance Sheet Claims With Independent Third-Party Actuarial Valuation

  • ORLANDO, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today provided the following response to last week's false and misleading short attack.
  • 06/10/2025

Bragar Eagel & Squire, P.C. Is Investigating GoHealth and Abacus and Encourages Investors to Contact the Firm

  • NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoHealth, Inc. (NASDAQ:GOCO) and Abacus Global Management, Inc. (NASDAQ:ABL). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
  • 06/09/2025

Abacus Global Management Investors May Be Able to Recover Losses By Contacting Block & Leviton LLP

  • BOSTON, MA / ACCESS Newswire / June 9, 2025 / Block & Leviton is investigating Abacus Global Management, Inc. (NASDAQ:ABL) for potential securities law violations. Investors who have lost money in their Abacus Global Management, Inc. investment should contact the firm to learn more about how they might recover those losses.
  • 06/09/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ:ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
  • 06/09/2025

ABL INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Launches Investigation into Abacus Global Management, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact Law Firm

  • SAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Abacus Global Management, Inc. (NASDAQ: ABL) focused on whether Abacus Global and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors.
  • 06/09/2025

ABL Investors Have Opportunity to Join Abacus Global Management, Inc. Fraud Investigation with the Schall Law Firm

  • LOS ANGELES--(BUSINESS WIRE)--ABL Investors Have Opportunity to Join Abacus Global Management, Inc. Fraud Investigation with the Schall Law Firm.
  • 06/07/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK , June 7, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
  • 06/07/2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

  • NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
  • 06/06/2025

Abacus Global authorizes $20M share repurchase, signals confidence in long-term growth

  • Abacus Global Management (NASDAQ:ABL) said on Friday it has authorized a $20 million share repurchase program, underscoring its confidence in the company's fundamentals and future performance. The repurchase program, approved by Abacus's Board of Directors, will be in effect for up to 18 months.
  • 06/06/2025

Abacus Global Management Announces Share Repurchase Program; Insider Buying

  • ORLANDO, Fla., June 06, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today announced that its Board of Directors has authorized a new $20 million share repurchase program, effective June 5, 2025 for over a period of up to 18 months, as well as recent Form 4 and other employee share purchases totaling over $2 million.
  • 06/06/2025

ABL ALERT: Levi & Korsinsky Investigates Abacus Global Management, Inc. on Behalf of Shareholders Who Lost Money

  • NEW YORK, NY / ACCESS Newswire / June 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Abacus Global Management, Inc. ("Abacus Global Management, Inc.") (NASDAQ:ABL) concerning possible violations of federal securities laws. On June 4, 2025, Morpheus Research published a report alleging the company is generating fake revenue through aggressive "mark-to-model" accounting tied to its life settlements portfolio.
  • 06/05/2025

ABACUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Abacus Global Management, Inc. on Behalf of Abacus Stockholders and Encourages Investors to Contact the Firm

  • NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ:ABL) on behalf of Abacus stockholders. Our investigation concerns whether Abacus has violated the federal securities laws and/or engaged in other unlawful business practices.
  • 06/05/2025

Securities Fraud Investigation Into Abacus Global Management, Inc. (ABL) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

  • LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ABACUS GLOBAL MANAGEMENT, INC. (ABL), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Wha.
  • 06/05/2025

Ongoing Investigation: Abacus Global Management, Inc. (ABL) May Have Misled Shareholders - Levi & Korsinsky Investigates

  • NEW YORK, NY / ACCESS Newswire / June 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Abacus Global Management, Inc. ("Abacus Global Management, Inc.") (NASDAQ:ABL) concerning possible violations of federal securities laws. On June 4, 2025, Morpheus Research published a report alleging the company is generating fake revenue through aggressive "mark-to-model" accounting tied to its life settlements portfolio.
  • 06/05/2025

Abacus Global Management riding wave of life settlements growth after Q1 earnings beat

  • Abacus Global Management (NASDAQ:ABL) is quickly proving its mettle in the alternative asset management space, delivering strong first-quarter earnings that exceeded Wall Street expectations and showcased the firm's growing dominance in life settlements and adjacent financial services. The company posted adjusted earnings per share (EPS) of $0.18 for the first quarter of fiscal 2025, beating consensus estimates of $0.16 and driven by record capital deployment and strong performance in its Life Solutions and Asset Management businesses.
  • 05/15/2025

Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress For Preclinical Data on Novel Allosteric BCR-ABL Inhibitor TERN-701

  • Preclinical data highlight improved potency vs. asciminib across multiple clinically relevant variants of BCR-ABL including difficult-to-treat resistance mutations
  • 05/14/2025

Abacus Life, Inc. (ABL) Upgraded to Buy: Here's Why

  • Abacus Life, Inc. (ABL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
  • 05/13/2025

Wall Street Analysts Predict a 57.47% Upside in Abacus Life, Inc. (ABL): Here's What You Should Know

  • The consensus price target hints at a 57.5% upside potential for Abacus Life, Inc. (ABL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
  • 05/13/2025

Is Abacus Life, Inc. (ABL) Outperforming Other Finance Stocks This Year?

  • Here is how Abacus Life, Inc. (ABL) and Annaly Capital Management (NLY) have performed compared to their sector so far this year.
  • 05/13/2025

Abacus Global Management Announces Virtual Livestream Details for the Abacus Investor Day and Longevity Summit on Thursday, June 12th, 2025

  • ORLANDO, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today announced details for the virtual livestream of the Abacus Investor Day and Longevity Summit to be held on Thursday, June 12, 2025, beginning at 9:30AM ET.
  • 05/13/2025

Abacus Global Management, Inc. (ABL) Q1 2025 Earnings Call Transcript

  • Abacus Global Management, Inc. (NASDAQ:ABL ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Robert Phillips - Senior Vice President-Investor Relations & Corporate Affairs Jay Jackson - Chairman & Chief Executive Officer Bill McCauley - Chief Financial Officer Conference Call Participants Patrick Davitt - Autonomous Research Crispin Love - Piper Sandler Randy Binner - B. Riley Andrew Kligerman - TD Securities Mike Grondahl - Northland Securities Operator Greetings, and welcome to the Abacus Global Management First Quarter 2025 Earnings Call.
  • 05/09/2025

Abacus Life, Inc. (ABL) Q1 Earnings and Revenues Top Estimates

  • Abacus Life, Inc. (ABL) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.11 per share a year ago.
  • 05/08/2025

Abacus Global Management doubles revenue, adjusted earnings in Q1 on strong asset inflows

  • Abacus Global Management (NASDAQ:ABL) more than doubled its revenue and adjusted earnings in the first quarter of 2025, driven by increased capital deployment and rising demand for alternative assets, the company said on Thursday. The New York-based asset manager posted total revenue of $44.1 million for the quarter ended March 31, up from $21.5 million a year earlier, fueled by gains in its Life Solutions business and a full quarter of fees from acquisitions completed late last year.
  • 05/08/2025

Abacus Global Management Reports First Quarter 2025 Results

  • – First Quarter 2025 Total Revenue More Than Doubled Year-over-Year to $44.1 Million – - Longevity Funds Attracted $122.8 Million in Capital Inflows - – GAAP Net Income of $4.6 Million – – Adjusted Net Income Grew 158% Year-over-Year to $17.3 Million – – Adjusted EBITDA More Than Doubled Year-over-Year to $24.5 Million – ORLANDO, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today reported results for the first quarter ended March 31, 2025.
  • 05/08/2025

Abacus Life, Inc. (ABL) Reports Next Week: Wall Street Expects Earnings Growth

  • Abacus Life, Inc. (ABL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 05/01/2025

Is the Options Market Predicting a Spike in Abacus Life Stock?

  • Investors need to pay close attention to ABL stock based on the movements in the options market lately.
  • 04/24/2025

Abacus Global Management sees increased demand as market volatility boosts interest in alternative funds

  • Abacus Global Management (NASDAQ:ABL) has highlighted that it remains well-positioned to benefit from ongoing market volatility, citing structural strengths in its business model and continued demand for alternative investments. The company, which operates in the alternative asset management sector, said it has seen a rise in origination and investor interest as traditional markets remain turbulent.
  • 04/07/2025

Abacus Global Management Well-Positioned Amid Market Volatility

  • ORLANDO, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, commented on the ongoing macro environment, noting that it remains well-positioned to capitalize on current market volatility, according to Chairman and Chief Executive Officer Jay Jackson. The Company's unique business model provides it with clear strategic advantages in uncertain market conditions.
  • 04/07/2025

Abacus Global Management transforms life insurance as an alternative asset class

  • Life insurance is often seen as a safety net — a financial cushion for loved ones after a policyholder's death. But for those who understand its true value, life insurance can also serve as a unique and underutilized asset class, offering opportunities for investment and financial planning far beyond its intended purpose.
  • 04/07/2025

ABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK to Develop Novel Medicines for Neurodegenerative Diseases

  • - ABL Bio and GSK enter into a multi-program agreement to develop novel medicines for neurodegenerative diseases - Programs will leverage ABL Bio's Grabody-B platform technology to effectively deliver molecules a cross the blood-brain barrier - ABL Bio to receive up to £77 million in upfront and near-term payments  SEONGNAM, South Korea , April 6, 2025 /PRNewswire/ -- ABL Bio Inc. (KOSDAQ: 298380), a clinical-stage biotech company developing bispecific antibody technology for immuno-oncology and neurodegenerative diseases, announced a worldwide licensing agreement enabling GSK to develop novel medicines for neurodegenerative diseases by utilizing ABL Bio's blood-brain barrier (BBB) shuttle platform, Grabody-B. The agreement aims to develop multiple programs for novel targets across therapeutic modalities including antibody, polynucleotide or oligonucleotides, such as siRNA and ASOs, to address significant unmet medical needs of patients suffering from neurodegenerative conditions.
  • 04/06/2025

Abacus Global Management sees revenue surge in 2024 – ICYMI

  • Abacus Global Management (NASDAQ:ABL) earlier this week told investors it expects adjusted net income to grow by between 51% and 68% in 2025. The company reported full-year 2024 revenue growth of 69% year-over-year.
  • 04/04/2025

Wall Street Analysts See a 76.37% Upside in Abacus Life, Inc. (ABL): Can the Stock Really Move This High?

  • The mean of analysts' price targets for Abacus Life, Inc. (ABL) points to a 76.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
  • 04/03/2025

4 Stocks to Watch From a Prospering Life Insurance Industry

  • Redesigning and repricing of products and services amid a low rate environment are likely to help Zacks Life Insurance industry players like AVVIY, NNGRY, JXN and ABL. These companies are investing heavily in digitization.
  • 04/01/2025

Abacus Life, Inc. (ABL) Q4 2024 Earnings Conference Call Transcript

  • Abacus Life, Inc. (NASDAQ:ABL ) Q4 2024 Earnings Conference Call March 27, 2025 5:00 PM ET Company Participants Robert Phillips - SVP, IR and Corporate Affairs Jay Jackson - Chairman and CEO Bill McCauley - CFO Conference Call Participants Patrick Davitt - Autonomous Research Crispin Love - Piper Sandler Randy Binner - B. Riley Securities Mike Grondahl - Northland Securities Andrew Kligerman - TD Securities Operator Good day, ladies and gentlemen, and thank you for standing by.
  • 03/27/2025

Abacus Life, Inc. (ABL) Surpasses Q4 Earnings and Revenue Estimates

  • Abacus Life, Inc. (ABL) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to loss of $0.10 per share a year ago.
  • 03/27/2025

Abacus Global Management forecasts over 50% growth in 2025 adjusted net income following strong Q4

  • Abacus Global Management (NASDAQ:ABL) reported a 40% increase in fourth-quarter revenue, reaching $33.2 million, as the alternative asset manager expanded its operations through strategic acquisitions and capital deployment. For the full year 2024, revenue surged 69% to $111.9 million, while adjusted net income climbed 58% to $46.5 million.
  • 03/27/2025

Abacus Global Management Reports Fourth Quarter and Full Year 2024 Results

  • - Delivered Record Full Year Revenue and Growth While Executing on Strategic Acquisitions and Initiatives -
  • 03/27/2025

KLX Energy Services Holdings, Inc. Closes on New $232 Million Senior Secured Notes and $125 Million ABL Credit Facility

  • HOUSTON , March 12, 2025 /PRNewswire/ -- KLX Energy Services Holdings, Inc. (Nasdaq: KLXE) ("KLX", the "Company", "we", "us" or "our") announced today that it has closed on refinancing its existing 2025 senior secured notes by issuing approximately $232 million of senior secured notes due March 2030 together with warrants to purchase common stock of the Company. The Company also announced it has closed on its new ABL credit facility due March 2028 with a $125 million commitment, a first-in-last-out facility with a $10 million commitment, and a committed incremental loan option with a $25 million commitment.
  • 03/12/2025

Abacus Life rebrands as Abacus Global Management

  • Abacus Life Inc (NASDAQ:ABL) announced on Tuesday that it has rebranded as Abacus Global Management, a move aimed at reflecting its broadened global presence and diversified financial services portfolio. The alternative asset manager said the rebrand underscores its strategic focus on technology-driven financial solutions, spanning life insurance assets, wealth management, and institutional investment services.
  • 03/11/2025

Abacus Life gains analyst support as it expands asset management business

  • Abacus Life Inc (NASDAQ:ABL) is gaining traction among analysts as it transitions from a life settlements firm into a broader asset management player. Analysts at Autonomous Research, Northland, and Piper Sandler see the alternative asset management company as significantly undervalued, with a strong market position, growing revenue streams, and potential for valuation upside.
  • 02/27/2025

Abacus Life to Announce Fourth Quarter 2024 Financial Results on Thursday, March 27, 2025

  • ORLANDO, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering global alternative asset manager specializing in leveraging longevity data and actuarial technology to offer uncorrelated investment opportunities, today announced it will release its fourth quarter 2024 financial results after the market closes on Thursday, March 27, 2025.
  • 02/25/2025

Abacus Life Announces Private Exchange of Outstanding Public Warrants

  • ORLANDO, Fla., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in leveraging longevity and actuarial technology to offer uncorrelated investment opportunities, today announced that it has entered into warrant exchange agreements (each, an “Exchange Agreement”) with certain holders (the “Holders”) of its outstanding publicly traded warrants (the “Public Warrants”) to purchase shares of the Company's common stock, par value $0.0001 per share (“Common Stock”). Pursuant to their respective Exchange Agreements, the Holders agreed to surrender an aggregate of 4,930,745 Public Warrants in exchange for an aggregate of 1,134,071 shares of newly issued Common Stock, representing a ratio of 0.23 shares per warrant.1
  • 02/24/2025

Abacus Life rebrands FCF Advisors, launches new small-cap ETF

  • Abacus Life Inc (NASDAQ:ABL) said on Wednesday it has rebranded FCF Advisors as Abacus FCF Advisors, a subsidiary of ABL Wealth, as part of its expansion into free cash flow-focused investment strategies. As part of the transition, Abacus FCF Advisors launched the Abacus FCF Small Cap Leaders ETF (ABLS) and announced management fee reductions of five to 10 basis points across all its ETFs.
  • 02/19/2025

Abacus Life Completes the Rebranding of FCF Advisors with New ETF and Fee Reductions

  • ORLANDO, Fla., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering global alternative asset manager specializing in leveraging longevity data and actuarial technology to offer uncorrelated investment opportunities, today announces the rebranding of FCF Advisors to Abacus FCF Advisors, a subsidiary of ABL Wealth.
  • 02/19/2025

Acuity Brands Inc.: Stay Bullish As Growth Should Turn Better

  • I maintain a buy rating on Acuity Brands Inc. due to strong growth prospects in both ABL and ISG segments, supported by positive demand indicators. 1Q25 results showed 2% y/y revenue growth to $952 million, driven by ABL's stable performance and ISG's 15% y/y growth, with notable margin expansion. Easing interest rates and a robust non-residential construction pipeline, evidenced by the Dodge Momentum Index, bolster ABL's growth outlook for FY25.
  • 01/12/2025

NN, Inc. Announces New Asset-Based Lending Facility

  • New ABL facility marks successful next step in Company's balance sheet optimization strategy New ABL facility marks successful next step in Company's balance sheet optimization strategy
  • 01/02/2025

Abacus Life, Inc. (ABL) Upgraded to Strong Buy: Here's What You Should Know

  • Abacus Life, Inc. (ABL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
  • 12/26/2024

Wall Street Analysts Think Abacus Life, Inc. (ABL) Could Surge 86.27%: Read This Before Placing a Bet

  • The average of price targets set by Wall Street analysts indicates a potential upside of 86.3% in Abacus Life, Inc. (ABL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
  • 12/23/2024

Abacus Life Completes Acquisition of FCF Advisors

  • ORLANDO, Fla., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering global alternative asset manager specializing in leveraging longevity data and actuarial technology to offer uncorrelated investment opportunities, today announced it has completed the acquisition of FCF Advisors (“FCF”), a New York-based asset manager and index provider specializing in free cash flow-focused investment strategies. The acquisition of FCF, which currently has approximately $850 million in assets under management, constitutes a significant milestone in Abacus' ongoing expansion of ABL Wealth and its suite of products.
  • 12/02/2024

Abacus Life Completes Acquisition of Carlisle Management Company S.C.A.

  • ORLANDO, Fla., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering global alternative asset manager specializing in leveraging longevity data and actuarial technology to offer uncorrelated investment opportunities, today announced it has completed the acquisition of Carlisle Management Company S.C.A. (“Carlisle”), a leading Luxembourg-based investment fund manager in the life settlement space with over U.S. $2 billion in assets under management. The Carlisle acquisition marks a key milestone in Abacus's stated strategy to drive long-term growth and diversify its value proposition through expanded global alternative asset-management offerings.
  • 12/02/2024

Abacus Life Targets Close of the Acquisition of Carlisle Management Company S.C.A. for December 2, 2024 with Receipt of Regulatory Non-Objection

  • ORLANDO, Fla., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering global alternative asset manager specializing in leveraging longevity data and actuarial technology to offer uncorrelated investment opportunities, announced it has received regulatory non-objection from the Luxembourg Commission de Surveillance du Secteur Financier (“CSSF”) for the acquisition of Carlisle Management Company S.C.A. (“Carlisle”), a leading Luxembourg-based investment fund manager in the life settlement space.
  • 11/26/2024

Abacus Life Announces Closing of Public Offering of 12,500,000 Shares of Common Stock

  • ORLANDO, Fla., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the closing of its oversubscribed underwritten public offering of 12,500,000 shares of its common stock, consisting of 10,000,000 shares of its common stock sold by the Company and 2,500,000 shares of common stock sold by certain stockholders of the Company (the “Selling Stockholders”) at the public offering price of $8.00 per share. The gross proceeds raised in the offering, before underwriting discounts and commissions and estimated expenses of the offering, were approximately $100 million, of which approximately $80 million was raised in the primary offering by the Company and approximately $20 million was paid in connection with the sale of shares by the Selling Stockholders.
  • 11/25/2024

Abacus Life's CEO on Cracking the Code of Longevity Returns

  • Abacus Life, Inc. NASDAQ: ABL is a global alternative asset manager specializing in a unique niche within the financial markets. The company acquires and manages life insurance policies.
  • 11/25/2024

Abacus Life Announces Pricing of Public Offering of Common Stock

  • ORLANDO, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the pricing of its underwritten public offering of 12,500,000 shares of its common stock, including 10,000,000 shares of common stock being offered by the Company and 2,500,000 shares of common stock being offered by certain stockholders of the Company (the “Selling Stockholders”), at a price to the public of $8.00 per share. In connection with the offering, the Company also granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock from the Company and up to an additional 375,000 shares of common stock from the Selling Stockholders at the public offering price. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $100 million, excluding any exercise of the underwriters' option to purchase additional shares.
  • 11/21/2024

Abacus Life Announces Proposed Public Offering of Common Stock

  • ORLANDO, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in leveraging longevity and actuarial technology to offer uncorrelated investment opportunities, today announced the commencement of an underwritten public offering of 12,500,000 shares of its common stock, including 10,000,000 shares of common stock to be sold by the Company and 2,500,000 to be sold by certain stockholders of the Company (the “Selling Stockholders”). The Company and the Selling Stockholders also expect to grant the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock from the Company and up to an additional 375,000 shares of common stock from the Selling Stockholders.
  • 11/21/2024

Wall Street Analysts Believe Abacus Life, Inc. (ABL) Could Rally 59.48%: Here's is How to Trade

  • The average of price targets set by Wall Street analysts indicates a potential upside of 59.5% in Abacus Life, Inc. (ABL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
  • 11/21/2024

Abacus Life, Inc. (ABL) Q3 2024 Earnings Call Transcript

  • Abacus Life, Inc. (NASDAQ:ABL ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Robert Phillips – Senior Vice President- Investor Relations and Corporate Affairs Jay Jackson – Chairman and Chief Executive Officer Bill McCauley – Chief Financial Officer Conference Call Participants Crispin Love – Piper Sandler Andrew Kligerman – TD Cowen Mike Grondahl – Northland Securities Operator Good day, ladies and gentlemen, and thank you for standing by. At this time all participants are in a listen-only mode.
  • 11/09/2024

Abacus Life, Inc. (ABL) Surpasses Q3 Earnings and Revenue Estimates

  • Abacus Life, Inc. (ABL) came out with quarterly earnings of $0.20 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.01 per share a year ago.
  • 11/07/2024

Abacus Life Reports Third Quarter 2024 Results

  • - Delivered Continued Revenue and Profitability Growth While Executing on Strategic Initiatives - - Third Quarter 2024 Total Revenue Grows 33% Year-over-Year to $28.1 Million - - Due to Non-Cash Increase in Warrant Liability of $8.7M; GAAP Net Loss of $5.1M - - Adjusted Net Income Grows 65% Year-over-Year to $14.9 Million - - Adjusted EBITDA Grows 54% Year-over-Year to $16.7 Million - ORLANDO, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering global alternative asset manager specializing in leveraging longevity data and actuarial technology to offer uncorrelated investment opportunities, today reported results for the third quarter ended September 30, 2024.
  • 11/07/2024

Abacus Life, Inc. (ABL) Earnings Expected to Grow: Should You Buy?

  • Abacus Life, Inc. (ABL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 10/31/2024

Cambridge Savings Bank Extends New Credit Facility to Accelerate Growth for Fabrizia Spirits

  • CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #SMBs--Cambridge Savings Bank has provided a new credit facility to Fabrizia Spirits, a leading citrus spirits manufacturer in the United States.
  • 10/17/2024

Abacus Life to Announce Third Quarter 2024 Financial Results on Thursday, November 7, 2024

  • ORLANDO, Fla., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading global alternative asset manager focused on lifespan-based financial products, today announced it will release its Third Quarter 2024 financial results after the market closes on Thursday, November 7, 2024.
  • 10/11/2024

What Makes Abacus Life, Inc. (ABL) a Strong Momentum Stock: Buy Now?

  • Does Abacus Life, Inc. (ABL) have what it takes to be a top stock pick for momentum investors? Let's find out.
  • 09/24/2024

Buy 4 Low-Beta Stocks & Forget About Volatility: ERIE, SFM, AVO, ABL

  • It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. ERIE, SFM, AVO & ABL are well-poised to gain.
  • 09/19/2024

Strength Seen in Abacus Life, Inc. (ABL): Can Its 5.4% Jump Turn into More Strength?

  • Abacus Life, Inc. (ABL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
  • 09/19/2024

Does Abacus Life, Inc. (ABL) Have the Potential to Rally 34.62% as Wall Street Analysts Expect?

  • The mean of analysts' price targets for Abacus Life, Inc. (ABL) points to a 34.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
  • 09/19/2024

Abacus Life Policy Value Calculator Surpasses Milestone of 150,000 Policy Valuations

  • ORLANDO, Fla., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading global alternative asset manager focused on lifespan-based financial products, today announced that its popular Abacus Policy Value Calculator, which recently launched its newest generation, has surpassed 150,000 individual submissions from insureds, totaling more than $87 billion in face value.
  • 09/18/2024

Corey McLaren Joins Abacus Life (ABL) as Managing Director, Capital Markets

  • ORLANDO, Fla., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading global alternative asset manager focused on lifespan-based financial products, today announced that Corey McLaren has joined Abacus as Managing Director, Capital Markets.
  • 09/16/2024

Can Abacus Life, Inc. (ABL) Run Higher on Rising Earnings Estimates?

  • Abacus Life, Inc. (ABL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
  • 09/02/2024

Wall Street Analysts Predict a 32.72% Upside in Abacus Life, Inc. (ABL): Here's What You Should Know

  • The consensus price target hints at a 32.7% upside potential for Abacus Life, Inc. (ABL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
  • 08/26/2024

Abacus Life and Lorisco Life Announce Launch of PREADISAN™ to Improve Health Predictions

  • ORLANDO, Fla and NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, and Lorisco Life LLC (“Lorisco”), a health prediction company using modern proteomics and machine learning to accurately forecast health events, today announced a new partnership and product launch to revolutionize longevity-based health prediction and actuarial technology.
  • 08/19/2024

Abacus Life, Inc. (ABL) Q2 2024 Earnings Call Transcript

  • Abacus Life, Inc. (NASDAQ:ABL ) Q2 2024 Earnings Conference Call August 12, 2024 9:00 AM ET Company Participants Garrett Edson - Managing Director ICR Jay Jackson - Chief Executive Officer Bill McCauley - Chief Financial Officer Conference Call Participants Crispin Love - Piper Sandler Andrew Kligerman - TD Securities Matthew Howlett - B. Riley Securities Operator Greetings and welcome to Abacus Life Second Quarter '24 Earnings Call.
  • 08/12/2024

Abacus Life Reports Second Quarter 2024 Results

  • - Second Quarter 2024 Total Revenue More Than Doubled Year-over-Year to $29.1 Million - - Net Income of $0.8 Million; Adjusted Net Income Grows 75% Year-over-Year to $11.8 Million - - Adjusted EBITDA Grows 83% Year-over-Year to $16.7 Million - ORLANDO, Fla., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today reported results for the second quarter ended June 30, 2024.
  • 08/12/2024

Abacus Life, Inc. (ABL) Stock Jumps 20.3%: Will It Continue to Soar?

  • Abacus Life, Inc. (ABL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
  • 07/22/2024

Abacus Life Provides Preliminary Second Quarter 2024 Results

  • - Expects Total Revenue Between $28.0 and $30.0 Million; Grows 146-163% Year-over-Year - - Expects Net Income Between $0.0 and $1.0 Million - - Expects Adjusted EBITDA Between $15.0 and $17.0 Million; Grows 64-86% Year-over-Year - - Schedules Second Quarter 2024 Earnings Release and Conference Call for Monday, August 12, 2024 - ORLANDO, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced preliminary unaudited financial results for the second quarter ended June 30, 2024.
  • 07/18/2024

Abacus Life Announces Agreement to Acquire Carlisle Management Company SCA

  • Acquisition accelerates Abacus' expansion as a global alternative asset manager and origination company Deal will add up to $2 billion in AUM to Abacus ORLANDO, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, today announced a definitive agreement to acquire Carlisle Management Company SCA (“Carlisle”), a leading Luxembourg-based investment manager in the life settlement space, for approximately $200 million.
  • 07/18/2024

Abacus Life Announces Closing of Public Offering of 11,500,000 Shares of Common Stock

  • ORLANDO, Fla., June 24, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the closing of its oversubscribed underwritten public offering of 11,500,000 shares of its common stock, including the exercise in full by the underwriters of their option to purchase an additional 1,500,000 shares of common stock, at the public offering price of $8.00 per share. The gross proceeds raised in the offering, before underwriting discounts and commissions and estimated expenses of the offering, were approximately $92 million.
  • 06/24/2024

Why Is Abacus Life (ABL) Stock Down 18% Today?

  • Abacus Life (NASDAQ: ABL ) stock is falling on Friday after the alternative asset manager and market maker announced the pricing of a public offering for its shares. Abacus Life is selling 10 million shares of ABL stock for $8 each.
  • 06/21/2024

Smith & Wesson Brands, Abacus Life And Other Big Stocks Moving Lower In Friday's Pre-Market Session

  • U.S. stock futures were slightly lower this morning, with the Dow futures falling around 0.1% on Friday.
  • 06/21/2024

Abacus Life Announces Pricing of Public Offering of Common Stock

  • ORLANDO, Fla., June 20, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the pricing of its oversubscribed underwritten public offering of 10,000,000 shares of its common stock at a price to the public of $8.00 per share. In connection with the offering, the Company also granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock at the public offering price. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $80 million, excluding any exercise of the underwriters' option to purchase additional shares. All of the shares in the public offering are to be sold by Abacus.
  • 06/20/2024

Abacus Life Announces Proposed Public Offering of Common Stock

  • ORLANDO, Fla., June 13, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock. In connection with the offering, Abacus intends to grant the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock at the public offering price. All of the shares in the public offering are to be sold by Abacus.
  • 06/13/2024

The Deal's 2023 Annual Ranking Shows Abacus Life (ABL) Leads Life Settlement Industry with 26% Market Share in Funds Paid to Clients

  • ORLANDO, Fla., June 06, 2024 (GLOBE NEWSWIRE) --  Abacus Life, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a pioneering alternative asset manager specializing in longevity and actuarial technology, announced today that it led the life settlement industry in funds paid to clients in 2023 with a 26% market share according to The Deal, once again bringing premier value to its clients.
  • 06/06/2024

Wallbox Announces Six Month Milestones in The Acquisition of ABL, A German Leader in EV Charging

  • BARCELONA, Spain--(BUSINESS WIRE)--Wallbox, a global leader in electric vehicle (EV) charging and energy management solutions, announced a number of key strategic milestones since their acquisition of ABL, an industry pioneer and German leader in EV charging. The integration of ABL into the Wallbox Group has already yielded encouraging results that will strengthen both companies' ability to support the EV transition. "We are immensely proud of what we have achieved in the first six months follo.
  • 05/22/2024

Alta Equipment Group Announces Proposed Private Offering of $500 Million of Senior Secured Second Lien Notes

  • LIVONIA, Mich., May 20, 2024 (GLOBE NEWSWIRE) -- Alta Equipment Group Inc. (NYSE: ALTG) (“Alta” or the “Company”), today announced that it intends to offer, subject to market and other conditions, $500 million in aggregate principal amount of its senior secured second lien notes due 2029 in a private offering (the “offering”) that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The notes will be guaranteed by all of the Company’s domestic subsidiaries and will be secured by a second lien on substantially all of the assets of the Company and its domestic subsidiaries. Concurrent with the closing of the offering, the Company expects to amend and extend its existing $485 million senior secured asset-based revolving credit facility due 2026 (the “Existing ABL Facility”) and $70 million floor plan facility due 2026 (the “Existing Floor Plan Facility”) with a $520 million senior secured asset-based revolving credit facility due 2029 (the “New ABL Facility”) and a $90 million floor plan facility due 2029 (together with the New ABL Facility, the “First Lien Facilities”). The First Lien Facilities will be secured by a first-priority lien on the same assets securing the notes. The Company intends to use the net proceeds from the offering, together with the proceeds of new borrowings under the First Lien Facilities, (i) to refinance a portion of the Existing ABL Facility and the Existing Floor Plan Facility prior to the amendments thereto, pay accrued and unpaid interest thereon, and pay related fees and expenses thereto, (ii) to redeem all of its outstanding 5.625% Senior Secured Second Lien Notes due 2026 (the “Existing Notes”), pay the premium, accrued and unpaid interest thereon, and pay related fees and expenses thereto, and (iii) for general corporate purposes to the extent there are any remaining proceeds. The offering and related refinancing is expected to be leverage neutral for the Company. The notes and the related guarantees will be offered only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act and to non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act. The offer and sale of the notes and the related guarantees have not been registered under the Securities Act or the securities laws of any state or other jurisdiction and may not be offered or sold absent registration or an applicable exemption from the registration requirements under the Securities Act and any applicable securities laws of any state or other jurisdiction. This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, any of the notes, nor shall there be any sale of the notes in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This press release is being issued pursuant to and in accordance with Rule 135(c) under the Securities Act. This press release does not constitute a notice of redemption with respect to the Existing Notes.Forward Looking Statements This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Alta’s actual results may differ from their expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside Alta’s control and are difficult to predict. Factors that may cause such differences include, but are not limited to: supply chain disruptions, inflationary pressures resulting from supply chain disruptions or a tightening labor market; negative impacts on customer payment policies and adverse banking and governmental regulations, resulting in a potential reduction to the fair value of our assets; the performance and financial viability of key suppliers, contractors, customers, and financing sources; economic, industry, business and political conditions including their effects on governmental policy and government actions that disrupt our supply chain or sales channels; fluctuations in interest rates; the market price for our equipment; collective bargaining agreements and our relationship with our union-represented employees; our success in identifying acquisition targets and integrating acquisitions; our success in expanding into and doing business in additional markets; our ability to raise capital at favorable terms; the competitive environment for our products and services; our ability to continue to innovate and develop new business lines; our ability to attract and retain key personnel, including, but not limited to, skilled technicians; our ability to maintain our listing on the New York Stock Exchange; the impact of cyber or other security threats or other disruptions to our businesses; our ability to realize the anticipated benefits of acquisitions or divestitures, rental fleet and other organic investments or internal reorganizations; federal, state, and local government budget uncertainty, especially as it relates to infrastructure projects and taxation; currency risks and other risks associated with international operations; and other risks and uncertainties indicated from time to time in the section entitled “Risk Factors” in Alta’s annual report on Form 10-K and other filings with the U.S. Securities and Exchange Commission. Alta cautions that the foregoing list of factors is not exclusive, and readers should not place undue reliance upon any forward-looking statements, which speak only as of the date made. Alta does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based.About Alta Equipment Group Inc. Alta owns and operates one of the largest integrated equipment dealership platforms in North America. Through our branch network, the Company sells, rents, and provides parts and service support for several categories of specialized equipment, including lift trucks and other material handling equipment, heavy and compact earthmoving equipment, crushing and screening equipment, environmental processing equipment, cranes and aerial work platforms, paving and asphalt equipment, other construction equipment and allied products. Alta has operated as an equipment dealership for 40 years and has developed a branch network that includes over 85 total locations across Michigan, Illinois, Indiana, Ohio, Pennsylvania, Massachusetts, Maine, Connecticut, New Hampshire, Vermont, Rhode Island, New York, Virginia, Nevada and Florida and the Canadian provinces of Ontario and Quebec. Alta offers its customers a one-stop-shop for their equipment needs through its broad, industry-leading product portfolio.ContactsInvestors:Kevin IndaSCR Partners, LLC kevin@scr-ir.com (225) 772-0254Media:Glenn MooreAlta Equipment glenn.moore@altg.com (248) 305-2134 Source: Alta Equipment Group2024 GlobeNewswire, Inc., source Press Releases
  • 05/20/2024

Alta Equipment Group Announces Proposed Private Offering of $500 Million of Senior Secured Second Lien Notes

  • LIVONIA, Mich., May 20, 2024 (GLOBE NEWSWIRE) -- Alta Equipment Group Inc. (NYSE: ALTG) (“Alta” or the “Company”), today announced that it intends to offer, subject to market and other conditions, $500 million in aggregate principal amount of its senior secured second lien notes due 2029 in a private offering (the “offering”) that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The notes will be guaranteed by all of the Company’s domestic subsidiaries and will be secured by a second lien on substantially all of the assets of the Company and its domestic subsidiaries. Concurrent with the closing of the offering, the Company expects to amend and extend its existing $485 million senior secured asset-based revolving credit facility due 2026 (the “Existing ABL Facility”) and $70 million floor plan facility due 2026 (the “Existing Floor Plan Facility”) with a $520 million senior secured asset-based revolving credit facility due 2029 (the “New ABL Facility”) and a $90 million floor plan facility due 2029 (together with the New ABL Facility, the “First Lien Facilities”). The First Lien Facilities will be secured by a first-priority lien on the same assets securing the notes. The Company intends to use the net proceeds from the offering, together with the proceeds of new borrowings under the First Lien Facilities, (i) to refinance a portion of the Existing ABL Facility and the Existing Floor Plan Facility prior to the amendments thereto, pay accrued and unpaid interest thereon, and pay related fees and expenses thereto, (ii) to redeem all of its outstanding 5.625% Senior Secured Second Lien Notes due 2026 (the “Existing Notes”), pay the premium, accrued and unpaid interest thereon, and pay related fees and expenses thereto, and (iii) for general corporate purposes to the extent there are any remaining proceeds. The offering and related refinancing is expected to be leverage neutral for the Company. The notes and the related guarantees will be offered only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act and to non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act. The offer and sale of the notes and the related guarantees have not been registered under the Securities Act or the securities laws of any state or other jurisdiction and may not be offered or sold absent registration or an applicable exemption from the registration requirements under the Securities Act and any applicable securities laws of any state or other jurisdiction. This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, any of the notes, nor shall there be any sale of the notes in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This press release is being issued pursuant to and in accordance with Rule 135(c) under the Securities Act. This press release does not constitute a notice of redemption with respect to the Existing Notes.Forward Looking Statements This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Alta’s actual results may differ from their expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside Alta’s control and are difficult to predict. Factors that may cause such differences include, but are not limited to: supply chain disruptions, inflationary pressures resulting from supply chain disruptions or a tightening labor market; negative impacts on customer payment policies and adverse banking and governmental regulations, resulting in a potential reduction to the fair value of our assets; the performance and financial viability of key suppliers, contractors, customers, and financing sources; economic, industry, business and political conditions including their effects on governmental policy and government actions that disrupt our supply chain or sales channels; fluctuations in interest rates; the market price for our equipment; collective bargaining agreements and our relationship with our union-represented employees; our success in identifying acquisition targets and integrating acquisitions; our success in expanding into and doing business in additional markets; our ability to raise capital at favorable terms; the competitive environment for our products and services; our ability to continue to innovate and develop new business lines; our ability to attract and retain key personnel, including, but not limited to, skilled technicians; our ability to maintain our listing on the New York Stock Exchange; the impact of cyber or other security threats or other disruptions to our businesses; our ability to realize the anticipated benefits of acquisitions or divestitures, rental fleet and other organic investments or internal reorganizations; federal, state, and local government budget uncertainty, especially as it relates to infrastructure projects and taxation; currency risks and other risks associated with international operations; and other risks and uncertainties indicated from time to time in the section entitled “Risk Factors” in Alta’s annual report on Form 10-K and other filings with the U.S. Securities and Exchange Commission. Alta cautions that the foregoing list of factors is not exclusive, and readers should not place undue reliance upon any forward-looking statements, which speak only as of the date made. Alta does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based.About Alta Equipment Group Inc. Alta owns and operates one of the largest integrated equipment dealership platforms in North America. Through our branch network, the Company sells, rents, and provides parts and service support for several categories of specialized equipment, including lift trucks and other material handling equipment, heavy and compact earthmoving equipment, crushing and screening equipment, environmental processing equipment, cranes and aerial work platforms, paving and asphalt equipment, other construction equipment and allied products. Alta has operated as an equipment dealership for 40 years and has developed a branch network that includes over 85 total locations across Michigan, Illinois, Indiana, Ohio, Pennsylvania, Massachusetts, Maine, Connecticut, New Hampshire, Vermont, Rhode Island, New York, Virginia, Nevada and Florida and the Canadian provinces of Ontario and Quebec. Alta offers its customers a one-stop-shop for their equipment needs through its broad, industry-leading product portfolio.ContactsInvestors:Kevin IndaSCR Partners, LLC kevin@scr-ir.com (225) 772-0254Media:Glenn MooreAlta Equipment glenn.moore@altg.com (248) 305-2134 Source: Alta Equipment Group2024 GlobeNewswire, Inc., source Press Releases
  • 05/20/2024

Abacus Life, Inc. (ABL) Q1 2024 Earnings Call Transcript

  • Abacus Life, Inc. (NASDAQ:ABL ) Q1 2024 Earnings Conference Call May 13, 2024 9:00 AM ET Company Participants Garrett Edson - Investor Relations Jay Jackson - Chief Executive Officer Bill McCauley - Chief Financial Officer Conference Call Participants Wilma Burdis - Raymond James Andrew Kligerman - TD Cowen Matthew Howlett - B. Riley Securities Operator Greetings and welcome to Abacus Life First Quarter 2024 Earnings Call.
  • 05/13/2024

Abacus Life Reports First Quarter 2024 Results

  • - First Quarter 2024 Total Revenue More Than Doubled Year-over-Year to $21.5 Million - - Driven by 59% Year-over-Year Growth in Direct-to-Consumer Division - ORLANDO, Fla., May 13, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today reported results for the first quarter ended March 31, 2024.
  • 05/13/2024

Fei Xue Appointed as Vice President of ABL Wealth at Abacus Life

  • Launched in 2023, ABL Wealth has Aggressive Expansion Plans and Unique Lifespan-Driven Financial Planning and Investment Offerings Launched in 2023, ABL Wealth has Aggressive Expansion Plans and Unique Lifespan-Driven Financial Planning and Investment Offerings
  • 04/18/2024

Abacus Life: Leader In Life Settlement Space

  • Abacus Life reported $79.6m of full-year revenue, growing 14% YoY, and $39.3m of adjusted EBITDA for the full year, growing 13% YoY. Abacus highlighted two key items coming in 2024 to drive growth: the launch of a 40 Act Fund and expansion into tangential markets. Abacus has made progress in its capital structure, authorizing a share buyback, placing an offering, and seeing warrant exercises.
  • 04/09/2024

Elena Plesco Joins Abacus Life (ABL) as Chief Capital Officer

  • ORLANDO, Fla., April 02, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, today announced that Elena Plesco has joined Abacus as Chief Capital Officer.
  • 04/02/2024

Abacus Life, Inc. (ABL) Q4 2023 Earnings Call Transcript

  • Abacus Life, Inc. (ABL) Q4 2023 Earnings Call Transcript
  • 03/21/2024

Abacus Life Reports Fourth Quarter and Full Year 2023 Results

  • - Fourth Quarter 2023 Total Revenue Grew 25% Year-over-Year to $23.6 Million - - Increased Originations Capital Deployment by 92% Year-over-Year to $68.3 Million - - Increased Originations Capital Deployment for Full Year 2023 by 46% to $218.9 Million - ORLANDO, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, today reported results for the quarter and full year ended December 31, 2023.
  • 03/21/2024

Abacus Life to Announce Fourth Quarter 2023 Financial Results on Thursday, March 21, 2024

  • ORLANDO, Fla., March 12, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, today announced it will release its Fourth Quarter 2023 financial results after the market closes on Thursday, March 21, 2024.
  • 03/12/2024

Glancy Prongay & Murray LLP Announces Investigation of Abacus Life, Inc. (ABL)

  • NEW YORK--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Abacus Life, Inc. (Nasdaq: ABL) concerning the Company and its directors' and officers' possible violations of state laws. If you own Abacus Life stock, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Tom Kennedy, of GPM, 230 Park Avenue, Suite 358, New York, NY 10169 at tkenned.
  • 03/05/2024

UPDATE – Abacus Life (ABL) Officially Launches Technology Sub-Division – ABL Tech

  • ORLANDO, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, is proud to announce the official expansion of ABL Tech, its technology division.
  • 02/27/2024

Abacus Life (ABL) Officially Launches Technology Sub-Division – ABL Tech

  • ORLANDO, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”) is a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products. The company is proud to announce the official expansion of its technology division, ABL Tech. This strategic move not only signifies growth but also a rebranding and evolution from the well-respected LMA Technologies. For years, LMA Technologies has been at the forefront of serving the life insurance sector, offering institutional investors comprehensive solutions including death audit tracking, valuation services, and critical data insights. ABL Tech is set to build on this legacy, redefining the technological landscape within the pension fund and financial services industry with a suite of tech-driven solutions.
  • 02/27/2024

Glancy Prongay & Murray LLP Announces Investigation of Abacus Life, Inc. (ABL)

  • NEW YORK--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Abacus Life, Inc. (Nasdaq: ABL) concerning the Company and its directors' and officers' possible violations of state laws. If you own Abacus Life stock, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Tom Kennedy, of GPM, 230 Park Avenue, Suite 358, New York, NY 10169 at tkenned.
  • 02/16/2024

Abacus Life Repurchases Total of $6 Million of Stock in First 60 Days of Program

  • ORLANDO, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, provided an update to its $15 million stock repurchase program previously announced on December 12, 2023 (the “Repurchase Program”).
  • 02/13/2024

Abacus Life, Inc. Prices Public Offering of $25 Million Additional 9.875% Notes Due 2028

  • ORLANDO, Fla., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL; ABLLL) today announced that it has priced an underwritten public offering of $25 million in aggregate principal amount of its additional 9.875% notes due 2028 (the “New Notes”). The New Notes will have the same terms (except with respect to issue date and the date from which interest will accrue) as, will be fully fungible with and will be treated as a single series of debt securities as, the 9.875% notes due 2028 the Company issued on November 10, 2023 in an aggregate principal amount of $35,650,000 (the “Existing Notes” and together with the New Notes, the “Notes”). When issued, the New Notes will bring the aggregate amount of Notes outstanding to $60,650,000. The Company has granted the underwriters an option to purchase up to an additional $3,750,000 in aggregate principal amount of New Notes solely to cover overallotments, if any. The offering is expected to close on February 15, 2024, subject to customary closing conditions. Piper Sandler & Co., A.G.P. / Alliance Global Partners, and Ladenburg Thalmann & Co. Inc. are serving as joint book-running managers for the offering.
  • 02/12/2024

Abacus Life CEO Jay Jackson Discusses Misconceptions About Life Insurance on the Wealthion Podcast

  • ORLANDO, Fla., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, announced today that Abacus Life CEO Jay Jackson appears as a guest on the Wealthion Podcast hosted by Eric Chemi. On the podcast, CEO Jackson discusses, among other things, the misconceptions about life insurance and the changing financial planning landscape.
  • 02/06/2024

Abacus Life CEO Jay Jackson Discusses Lifespan Data and Financial Planning on SPAC Insider Podcast

  • ORLANDO, Fla., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, announced today that Abacus Life CEO Jay Jackson appears as a guest on the SPACInsider Podcast hosted by Nicholas Clayton and Marlena Haddad. On the podcast, CEO Jackson discusses, among other things, the de-SPAC process and the undervalued importance of longevity data.
  • 02/02/2024

Abacus Life Repurchases $1.9 Million of Stock in First 30 Days of Program

  • ORLANDO, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, provided an update to its $15 million stock repurchase program previously announced on December 12, 2023 (the “Repurchase Program”).
  • 01/09/2024

Abacus Life Announces $15 Million Stock Repurchase Program

  • ORLANDO, Fla., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, announced today that its Board of Directors has authorized a new stock repurchase program of up to $15 million of the Company's outstanding common stock over a period of up to 18 months.
  • 12/12/2023

New Exchange Preferred Stock And Traded Debt IPOs, November 2023

  • New Exchange Preferred Stock And Traded Debt IPOs, November 2023
  • 12/04/2023

Abacus Life: Have They Cracked Life Settlements?

  • Abacus Life Settlements has emerged as a profitable opportunity in the SPAC wreckage, trading down about 35% since its merger. Abacus operates differently from its predecessor, Emergent Capital, by originating policies and selling them to investors or its subsidiary. Abacus has a proven track record of generating significant returns on investment and has attracted capital from major firms like KKR and Apollo.
  • 11/14/2023

Abacus Life to Announce Third Quarter 2023 Financial Results on Monday, November 13, 2023

  • ORLANDO, Fla., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading buyer of life insurance policies, policy originator and alternative asset manager specializing in specialty insurance products, today announced it will release its Third Quarter 2023 financial results before the market opens on Monday, November 13, 2023.
  • 10/17/2023

Top 5 Financial Stocks You'll Regret Missing This Quarter - Beneficient (NASDAQ:BENF), Abacus Life (NASDAQ:ABL)

  • The most oversold stocks in the financial sector presents an opportunity to buy into undervalued companies.
  • 08/03/2023

Abacus Life to Announce Second Quarter 2023 Financial Results on Monday, August 14, 2023

  • ORLANDO, Fla., July 24, 2023 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, today announced it will release its Second Quarter 2023 financial results before the market opens on Monday, August 14, 2023.
  • 07/24/2023
Unlock
ABL Ratings Summary
ABL Quant Ranking